Topped up in the low 50s for a long term hold.
$8 billion market and no serious competition.
This may dip further in the short term but strong news expected in Q3 and Q4.
Ann: First Patient Treatment in the U.S. in the VISABL-AFL Trial, page-2
Add IMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
88.5¢ |
Change
0.060(7.27%) |
Mkt cap ! $239.1M | |||
| Open | High | Low | Value | Volume |
| 82.5¢ | 88.5¢ | 82.5¢ | $107.2K | 125.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23668 | 84.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 88.5¢ | 5999 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| IMR (ASX) Chart |